Thyrosafe
NDC Package 66983-350-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Thyrosafe is use helps prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency. Marketed by Recipharm Ab (publ), this product is identified by NDC 66983-350 and is authorized under FDA application ANDA076350.

Identification & Billing

NDC Package Code
66983-350-20
Package Description
160 BOX in 1 CARTON / 20 BLISTER PACK in 1 BOX / 1 TABLET in 1 BLISTER PACK
Product Code
11-Digit Billing Format
66983035020
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
160 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Thyrosafe
Dosage Form
-
Usage Information
Use helps prevent radioactive iodine from getting into the thyroid gland during a nuclear radiation emergency. Use along with other emergency measures recommended by public officials.

Regulatory & Marketing

Labeler Name
Recipharm Ab (publ)
FDA Application #
ANDA076350
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-30-2002
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 66983-350-20 identifies a specific commercial package of 160 box in 1 carton / 20 blister pack in 1 box / 1 tablet in 1 blister pack of Thyrosafe, labeled by Recipharm Ab (publ). This product is billed for "EA" each discreet unit and contains an estimated amount of 160 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Recipharm Ab (publ) on September 30, 2002. The current certification is valid through December 31, 2022.

How is this Recipharm Ab (publ) product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 66983035020. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 160 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
66983-350-20
11-Digit CMS (5-4-2)
66983-0350-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.